Copyright @2025 All Right Reserved – FON Media, LLC
The Tel Aviv Family Office Association & Camelot Bio Capital
Join a discussion Led By Founders Dr. Peter Kash & Dr. Colby Kash Overviewing Their Investment Strategy & How They Source Undervalued Opportunities.
They both are prominent figures in the life sciences and biotechnology investment space through Camelot Bio Capital
November 14th, 2024
12:00pm – 2:00pm
Tel Aviv-Yafo, Israel
They both are prominent figures in the life sciences and biotechnology investment space through Camelot Bio Capital
November 14th, 2024
12:00pm – 2:00pm
Tel Aviv-Yafo, Israel
Dr. Peter Kash, a seasoned biopharmaceutical executive and co-founder of Camelot Bio Capital, brings over three decades of expertise in venture capital, focusing on the development and commercialization of innovative medical therapies. He has co-founded and invested in numerous biotech companies, playing a key role in driving their success and helping bring life-changing drugs to market.
Dr. Colby Kash, also a co-founder of Camelot Bio Capital, combines his medical and research expertise with strategic leadership to advance biotechnological innovations. Together, they leverage their extensive knowledge and experience to identify and fund promising biotech ventures, supporting breakthroughs in fields such as oncology, immunology, and regenerative medicine. Through Camelot Bio Capital, they aim to accelerate advancements in healthcare and improve patient outcomes by fostering cutting-edge medical technologies.
We are a premier platform dedicated to delivering insightful content and news tailored to the unique needs and interests of family offices and the luxury sector. Offering a blend of expert analysis and industry trends, FON Media serves as an essential resource for those navigating the exclusive world of wealth management and high-end living.